Award for Excellence in Research Enterprise and/or Commercialisation

19 November 2024

Dr Greg Stewart accepting the Vice-Chancellor’s Award for Excellence in Research Enterprise and/or Commercialisation.

On Tuesday 19 November, Monash University celebrated the annual Vice-Chancellor’s Excellence Awards.

Congratulations to Professor Chris Langmead and Dr Greg Stewart who were the winners of the award for Excellence in Research Enterprise and/or Commercialisation for their work in Translation and Commercialisation of Neuromedicines.

The development of new medicines for mental health and neurological conditions is a major area of unmet need and poorly addressed compared to other therapeutic areas.

Through the recently established Neuromedicines Discovery Centre, Professor Chris Langmead and Dr Greg Stewart have established a series of translational and commercial partnerships and ventures to combine the University's expertise in neuroscience and medicines development, resulting in a new pharmaceutical company partnership with Servier (France) and two new biotechnology start-ups, Pacalis Therapeutics and Phrenix Therapeutics.

Phrenix Therapeutics has been co-founded with Associate Professor Jess Nithianantharajah at The Florey for the development of new treatments for schizophrenia and cognitive disorders.